Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Brandon Wilbanks, LJ Maher$suffix/text()$suffix/text() & Moses Rodriguez. (2019) Glial cells as therapeutic targets in progressive multiple sclerosis. Expert Review of Neurotherapeutics 19:6, pages 481-494.
Read now
Read now
Fabiana Auricchio, Cristina Scavone, Daniela Cimmaruta, Gabriella Di Mauro, Annalisa Capuano, Liberata Sportiello & Concetta Rafaniello. (2017) Drugs approved for the treatment of multiple sclerosis: review of their safety profile. Expert Opinion on Drug Safety 16:12, pages 1359-1371.
Read now
Read now
Nukendra Prasad Nadella, Venkata Nadh Ratnakaram & N. Srinivasu. (2017) Quality-by-design-based development and validation of a stability-indicating UPLC method for quantification of teriflunomide in the presence of degradation products and its application to in-vitro dissolution. Journal of Liquid Chromatography & Related Technologies 40:10, pages 517-527.
Read now
Read now
Bhasker Sriramoju, Rupinder K Kanwar & Jagat R Kanwar. (2015) Neurobehavioral burden of multiple sclerosis with nanotheranostics. Neuropsychiatric Disease and Treatment 11, pages 2675-2689.
Read now
Read now
Yara Dadalti Fragoso & Joseph Bruno Bidin Brooks. (2015) Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases. Expert Review of Clinical Pharmacology 8:3, pages 315-320.
Read now
Read now
Arianna Sartori, Dawn Carle & Mark S Freedman. (2014)
Teriflunomide: a novel oral treatment for relapsing multiple sclerosis. Expert Opinion on Pharmacotherapy 15:7, pages 1019-1027.
Read now
Read now
Claudio Gasperini, Serena Ruggieri, Chiara Rosa Mancinelli & Carlo Pozzilli. (2013) Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod. Therapeutics and Clinical Risk Management 9, pages 73-85.
Read now
Read now
Alessandra Lugaresi, Maria di Ioia, Daniela Travaglini, Erika Pietrolongo, Eugenio Pucci & Marco Onofrj. (2013) Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatric Disease and Treatment 9, pages 893-914.
Read now
Read now
Kavitha Damal, Emily Stoker & John F Foley. (2013) Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action. Biologics: Targets and Therapy 7, pages 247-258.
Read now
Read now
Jagat R Kanwar, Bhasker Sriramoju & Rupinder K Kanwar. (2012) Neurological disorders and therapeutics targeted to surmount the blood–brain barrier. International Journal of Nanomedicine 7, pages 3259-3278.
Read now
Read now
Wolfgang Brück & Scott S Zamvil. (2012) Laquinimod, a once-daily oral drug in development for the treatment of relapsing–remitting multiple sclerosis. Expert Review of Clinical Pharmacology 5:3, pages 245-256.
Read now
Read now
Hans-Peter Hartung, Xavier Montalban, Per Soelberg Sorensen, Patrick Vermersch & Tomas Olsson. (2011) Principles of a new treatment algorithm in multiple sclerosis. Expert Review of Neurotherapeutics 11:3, pages 351-362.
Read now
Read now
Jean K Mah & Jennifer E Thannhauser. (2010) Management of multiple sclerosis in adolescents – current treatment options and related adherence issues. Adolescent Health, Medicine and Therapeutics 1, pages 31-43.
Read now
Read now
Anthony Slavin, Louise Kelly-Modis, Mark Labadia, Kelli Ryan & Maryanne L. Brown. (2010) Pathogenic mechanisms and experimental models of multiple sclerosis. Autoimmunity 43:7, pages 504-513.
Read now
Read now